EPO Patents = 2

Forward Citations = 2

Loading Chart...

5 inventors (with patents filed for the assignee):

Bin Liu (3 out of 164 patents)

Hang Cheng (3 out of 7 patents)

Chenggang Zhang (3 out of 4 patents)

4. Chengzhi Yu (3 out of 6 patents)

5. Weiyan Xiong (2 out of 5 patents)

3 patents: Sort by Forward Citations

1. 12428423 - 1H-imidazo[4,5-h]quinazoline compound as protein kinase inhibitor (2025-09-30),

2. 11993604 - Substituted pyrazolo[4,3-H]quinazolines as protein kinase inhibitors (2024-05-28),

3. 11091485 - Imidazo[1',2′:1,6]pyrido[2,3-d]pyrimidine compound as protein kinase inhibitor (2021-08-17),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#145 in Suzhou

#8,360 in China

Suzhou, China

Shengke Pharmaceuticals (Jiangsu) Ltd.

Forward Citations = 2

5 inventors:

Bin Liu (3 out of 164 patents)

Hang Cheng (3 out of 7 patents)

Chenggang Zhang (3 out of 4 patents)

4. Chengzhi Yu (3 out of 6 patents)

5. Weiyan Xiong (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shengke Pharmaceuticals (Jiangsu) Ltd.. Retrieved from https://idiyas.com/company/shengke-pharmaceuticals-jiangsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]